Conformis, Inc. revised revenue guidance for the fourth quarter of 2021. The company expects to report product revenue of approximately $15.3 million for the fourth quarter of 2021. This compares to the $15 million to $17 million range it referred to on November 3, 2021.
Conformis, Inc.
Equities
CFMS
US20717E2000
Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | |
---|---|---|
+11.75% | 13TCr | |
+2.18% | 1.23TCr | |
-18.47% | 710.07Cr | |
+56.20% | 677.83Cr | |
+9.27% | 346.93Cr | |
-15.41% | 259.94Cr | |
-18.25% | 191.49Cr | |
-27.00% | 161.87Cr | |
-37.52% | 144.6Cr |